Literature DB >> 2473672

High antibody levels against mouse laminin with specificity for galactosyl-(alpha 1-3)galactose in patients with inner ear diseases.

R Klein1, R Timpl, F R Zanetti, D Plester, P A Berg.   

Abstract

Sera of 413 patients with inner ear diseases were examined for ELISA binding to mouse laminin and compared to a normal group. Strongly enhanced antilaminin antibody reactions were observed in a large number of patients with sensorineural hearing loss (68%), tinnitus (60%), and sudden deafness (46%), but not in those with Meniere's disease (14%) or normal individuals (8%). Absorption experiments demonstrated that these antibodies are also responsible for the antisarcolemmal antibody pattern in the immunofluorescence test and for the reaction with pig kidney microsomes in the ELISA. Immunochemical studies showed that laminin binding of high or low titer in sera from patients and normal individuals is due to the Gal alpha 1-3Gal epitope present in N-linked oligosaccharides of mouse laminin. No reactions were observed with human laminin, which lacks this epitope. The findings suggest that high levels of antibodies against carbohydrate structures are triggered by persistent infections, providing some new insights about the possible cause of these diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473672     DOI: 10.1177/000348948909800708

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  7 in total

1.  Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopes.

Authors:  A Gabrielli; M Candela; A M Ricciatti; M L Caniglia; J Wieslander
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

Review 2.  Autoantibodies in primary biliary cirrhosis.

Authors:  P A Berg; R Klein
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Anti-laminin antibodies in inner ear diseases: a potential marker for infectious and post-infectious processes.

Authors:  F R Zanetti; D Plester; R Klein; Z Bursa-Zanetti; P A Berg
Journal:  Arch Otorhinolaryngol       Date:  1989

4.  Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions.

Authors:  R M Hamadeh; U Galili; P Zhou; J M Griffiss
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

5.  A randomised double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides and phospholipids.

Authors:  R Olin; R Klein; P A Berg
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

6.  Distribution of the PBC-specific- (M2) and the naturally-occurring mitochondrial antigen- (NOMAg) systems in plants.

Authors:  P Lang; R Klein; E W Becker; P A Berg
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

7.  Characteristic Cochlear Hypoplasia in Patients with Walker-Warburg Syndrome: A Radiologic Study of the Inner Ear in α-Dystroglycan-Related Muscular Disorders.

Authors:  G Talenti; C Robson; M S Severino; C A Alves; D Chitayat; H Dahmoush; L Smith; F Muntoni; S I Blaser; F D'Arco
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-29       Impact factor: 3.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.